Gutartige Parotistumore: moderne Therapiekonzepte

Zusammenfassung

Bei gutartigen Parotistumoren ist es ein vorrangiges Behandlungsziel, die Morbidität des operativen Eingriffs zu senken. Standardisiertes intraoperatives Vorgehen und Verfahren zur Minimierung des Operationsumfangs konnten das Risiko einer bleibenden Fazialisparese deutlich senken. Aktuelle evidenzbasierte Therapieverfahren und mögliche Komplikationen nach Parotidektomie werden in diesem Beitrag näher erläutert.

Abstract

Parotidectomy is the standard procedure for treatment of benign parotid tumors. Nowadays, one of the main objectives of surgery is to minimize morbidity. However, the debate about the appropriate surgical technique in parotid surgery is still ongoing. There is a high level of evidence, that limited parotidectomy techniques are associated with fewer complications and especially with lower prevalence of permanent facial nerve palsy and Frey´s syndrome. However, limited parotidectomy requires an accurate pre-selection of patients and a precise preoperative diagnostic work-up. This manuscript describes the current trends in surgery for benign parotid lesions and illustrates the treatment options for major post-parotidectomy complications.

Schlüsselwörter

benigner Parotistumor - Parotidektomie - evidenzbasierte Therapie - Frey-Syndrom - Warthin-Tumor - Fazialisparese

Key words

benign parotid lesion - management of complications - parotidectomy - evidence-based therapy - Frey´s syndrome - facial nerve palsy

• Literatur

• 1 Jensen JE, Schlattmann P, Guntinas-Lichius O. Stationäre Speicheldrüsenoperationen in Deutschland. Eine DRG-basierte Analyse der Jahre 2007–2011. Laryngorhinootologie 2016; 95: 620-626 doi: 10.1055/s-0041–107558
• 2 Luers JC, Guntinas-Lichius O, Klussmann JP. et al. The incidence of Warthin tumours and pleomorphic adenomas in the parotid gland over a 25-year period. Clin Otolaryngol 2016; 41: 793-797 doi: 10.1111/coa.12694
• 3 Mantsopoulos K, Koch M, Klintworth N. et al. Evolution and changing trends in surgery for benign parotid tumors. Laryngoscope 2015; 125: 122-127 doi: 10.1002/lary.24837
• 4 Thielker J, Grosheva M, Ihrler S. et al. Contemporary management of benign and malignant parotid tumors. Front Surg 2018; 5: 39 doi: 10.3389/fsurg.2018.00039
• 5 Guntinas-Lichius O. The facial nerve in the presence of a head and neck neoplasm: assessment and outcome after surgical management. Curr Opin Otolaryngol Head Neck Surg 2004; 12: 133-141
• 6 Preuss SF, Guntinas-Lichius O. [On the diagnosis and treatment of parotid gland tumors. Results of a nationwide survey of ENT hospitals in Germany]. HNO 2006; 54: 868-874
• 7 Sood AJ, Houlton JJ, Nguyen SA. et al. Facial Nerve Monitoring during Parotidectomy: A Systematic Review and Meta-analysis. Otolaryngol -- Head Neck Surg 2015; 152: 631-637 doi: 10.1177/0194599814568779
• 8 Guntinas-Lichius O, Gabriel B, Klussmann JP. Risk of facial palsy and severe Freyís syndrome after conservative parotidectomy for benign disease: analysis of 610 operations. Acta Otolaryngol 2006; 126: 1104-1109
• 9 Quer M, Vander Poorten V, Takes RP. et al. Surgical options in benign parotid tumors: a proposal for classification. Eur Arch Oto-Rhino-Laryngology 2017; 274: 3825-3836 doi: 10.1007/s00405–017–4650–4
• 10 Grosheva M, Horstmann L, Volk GF. et al. Frey‘s Syndrome after Superficial Parotidectomy: Role of the Sternocleidomastoid Muscle Flap. A prospective Nonramdomized Controlled Trial. Am J Surg 2016; 212: 740-747 doi: 10.1016/j.amjsurg.2016.01.020
• 11 Witt R. The incidence and management of siaolocele after parotidectomy. Otolaryngol Neck Surg 2009; 140: 871-874 doi: 10.1016/j.otohns.2009.01.021
• 12 Roh JL, Kim HS, Park CI. Randomized clinical trial comparing partial parotidectomy versus superficial or total parotidectomy. Br J Surg 2007; 94: 1081-1087 doi: 10.10027bjs.59.47
• 13 Albergotti W, Nguyen S, Zenk J. et al. Extracapsular dissection for benign parotid tumors: a meta-analysis. Laryngoscope 2012; 122: 1954-1960 doi: 10.1002/lary.23396
• 14 Dulguerov P, Todic J, Pusztaszeri M. et al. Why Do Parotid Pleomorphic Adenomas Recur? A Systematic Review of Pathological and Surgical Variables. Front Surg 2017; 15 (04) 26 doi: 10.3389/fsurg.2017.00026
• 15 Colella G, Cannavale R, Chiodini P. Meta-analysis of surgical approaches to the treatment of parotid pleomorphic adenomas and recurrence rates. J Cranio-Maxillofacial Surg 2014; 43: 738-745 doi: 10.1016/j.jcms.2015.03.017
• 16 Klussmann JP, Wittekindt C, Preuss SF. et al. High risk for bilateral Warthin tumor in heavy smokers – review of 185 cases. Acta Otolaryngol 2006; 126: 1213-1217 doi: 10.1080/00016480600740605
• 17 Grosheva M, Shabli S, Volk GF. et al. Sensation loss after superficial parotidectomy: A prospective controlled multicenter trial. Head Neck 2017; 39: 520-526 doi: 10.1002/hed.24647
• 18 George M, Karkos PD, Dwivedi RC. et al. Preservation of greater auricular nerve during parotidectomy?: Sensation, quality of life, and morbidity issues. A systematic review. Head Neck 2014; 36: 603-608 doi: 10.1002/hed.23292
• 19 Wolber P, Volk GF, Horstmann L. et al. Patientís Perspective on Long-term Complications after Superficial Parotidectomy for Benign Lesions: Prospective Analysis of a Two-Year Follow-Up. Clin Otolaryngol 2018; 26 doi: 10.1111/coa.13104
• 20 Ambro BT, Goodstein LA, Morales RE. et al. Evaluation of superficial musculoaponeurotic system flap and fat graft outcomes for benign and malignant parotid disease. Otolaryngol Head Neck Surg 2013; 148: 949-954 doi: 10.1177/0194599812474969
• 21 Curry JM, Fisher KW, Heffelfinger RN. et al. Superficial musculoaponeurotic system elevation and fat graft reconstruction after superficial parotidectomy. Laryngoscope 2008; 118: 210-215 doi: 10.1097/MLG.0b013e3181581f94
• 22 Barber F, Castillo F, D‘Oleo C. et al. Superficial musculoaponeurotic system flap in partial parotidectomy and clinical and subclinical Frey‘s syndrome. Cosmesis and quality of life. Head Neck 2014; 36: 130-136 doi: 10.1002/head.23215
• 23 Sykes J, Allak A, Palhazi P. et al. Anatomy for Facial Fillers: The Skin Surface and Beyond. Goldberg DJ. (ed) Dermal Fillers. Aesthet Dermatol. Basel: Karger; 2018. 4 10-26 doi: 10.1159/000479133
• 24 Witt RL, Pribitkin EA. How can Frey‘s syndrome be prevented or treated following parotid surgery?. Laryngoscope 2013; 123: 1573-1574 doi: 10.1002/lary.23779
• 25 Sanabria A, Kowalski L, Bradley P. Sternocleidomastoid muscle flap in preventing Freyís syndrome after parotidectomy: a systematic review. Head Neck 2012; 1-10 doi: 10.1002/hed.21722